Renal Toxicity

Maen Abdelrahim; Ala Abudayyeh

doi:10.1007/978-3-030-41008-7_16

Renal Toxicity

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

With the increasing use of immunotherapy, there has been an associated increased survival in many cancers but has also resulted in unregulated organ-specific toxicities. In this chapter, we discuss the renal toxicities associated with a checkpoint inhibitor (CPI) from the typical acute tubulointersitial nephritis to glomerulonephritis, their proposed mechanisms, and treatments. We also discuss the use of CPI and reactivation of preexisting auto-immune diseases and focus on renal cell cancer in setting of Chronic kidney disease (CKD). Transplant rejection in the setting of CPI use is yet to be further studied, and available data is presented in this chapter.

Original language	English (US)
Title of host publication	Advances in Experimental Medicine and Biology
Publisher	Springer
Pages	287-293
Number of pages	7
DOIs	https://doi.org/10.1007/978-3-030-41008-7_16
State	Published - 2020

Publication series

Name	Advances in Experimental Medicine and Biology
Volume	1244
ISSN (Print)	0065-2598
ISSN (Electronic)	2214-8019

Keywords

Acute interstitial nephritis
Autoimmune disease induction
Immune-related adverse events
Organ transplant rejection
Renal cell cancer

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/978-3-030-41008-7_16

Cite this

@inbook{e9a4246ed6f5472db92aee88d553cf10,

title = "Renal Toxicity",

abstract = "With the increasing use of immunotherapy, there has been an associated increased survival in many cancers but has also resulted in unregulated organ-specific toxicities. In this chapter, we discuss the renal toxicities associated with a checkpoint inhibitor (CPI) from the typical acute tubulointersitial nephritis to glomerulonephritis, their proposed mechanisms, and treatments. We also discuss the use of CPI and reactivation of preexisting auto-immune diseases and focus on renal cell cancer in setting of Chronic kidney disease (CKD). Transplant rejection in the setting of CPI use is yet to be further studied, and available data is presented in this chapter.",

keywords = "Acute interstitial nephritis, Autoimmune disease induction, Immune-related adverse events, Organ transplant rejection, Renal cell cancer",

author = "Maen Abdelrahim and Ala Abudayyeh",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Nature Switzerland AG.",

year = "2020",

doi = "10.1007/978-3-030-41008-7_16",

language = "English (US)",

series = "Advances in Experimental Medicine and Biology",

publisher = "Springer",

pages = "287--293",

booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Renal Toxicity

AU - Abdelrahim, Maen

AU - Abudayyeh, Ala

PY - 2020

Y1 - 2020

N2 - With the increasing use of immunotherapy, there has been an associated increased survival in many cancers but has also resulted in unregulated organ-specific toxicities. In this chapter, we discuss the renal toxicities associated with a checkpoint inhibitor (CPI) from the typical acute tubulointersitial nephritis to glomerulonephritis, their proposed mechanisms, and treatments. We also discuss the use of CPI and reactivation of preexisting auto-immune diseases and focus on renal cell cancer in setting of Chronic kidney disease (CKD). Transplant rejection in the setting of CPI use is yet to be further studied, and available data is presented in this chapter.

AB - With the increasing use of immunotherapy, there has been an associated increased survival in many cancers but has also resulted in unregulated organ-specific toxicities. In this chapter, we discuss the renal toxicities associated with a checkpoint inhibitor (CPI) from the typical acute tubulointersitial nephritis to glomerulonephritis, their proposed mechanisms, and treatments. We also discuss the use of CPI and reactivation of preexisting auto-immune diseases and focus on renal cell cancer in setting of Chronic kidney disease (CKD). Transplant rejection in the setting of CPI use is yet to be further studied, and available data is presented in this chapter.

KW - Acute interstitial nephritis

KW - Autoimmune disease induction

KW - Immune-related adverse events

KW - Organ transplant rejection

KW - Renal cell cancer

UR - http://www.scopus.com/inward/record.url?scp=85083631995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083631995&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-41008-7_16

DO - 10.1007/978-3-030-41008-7_16

M3 - Chapter

C2 - 32301023

AN - SCOPUS:85083631995

T3 - Advances in Experimental Medicine and Biology

SP - 287

EP - 293

BT - Advances in Experimental Medicine and Biology

PB - Springer

ER -

Renal Toxicity

Abstract

Publication series

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this